Format

Send to:

Choose Destination
See comment in PubMed Commons below
Infect Ecol Epidemiol. 2012;2. doi: 10.3402/iee.v2i0.18385. Epub 2012 Jun 21.

Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans - a review.

Author information

  • 1Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Abstract

The antiviral drug oseltamivir (Tamiflu(®)) is a cornerstone in influenza pandemic preparedness plans worldwide. However, resistance to the drug is a growing concern. The active metabolite oseltamivir carboxylate (OC) is not degraded in surface water or sewage treatment plants and has been detected in river water during seasonal influenza outbreaks. The natural influenza reservoir, dabbling ducks, can thus be exposed to OC in aquatic environments. Environmental-like levels of OC induce resistance development in influenza A/H1N1 virus in mallards. There is a risk of resistance accumulation in influenza viruses circulating among wild birds when oseltamivir is used extensively. By reassortment or direct transmission, oseltamivir resistance can be transmitted to humans potentially causing a resistant pandemic or human-adapted highly-pathogenic avian influenza virus. There is a need for more research on resistance development in the natural influenza reservoir and for a prudent use of antivirals.

KEYWORDS:

H274Y; antiviral; avian; oseltamivir carboxylate; pandemic; pharmaceuticals

PMID:
22957124
[PubMed]
PMCID:
PMC3426320
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Datapage Icon for PubMed Central
    Loading ...
    Write to the Help Desk